check_circleStudy Completed

Pulmonary Hypertension, Pulmonary Stenosis

Bayer Identifier:

Trial_1555

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Adalat drops and Adalat retard 10 mg tablets in children with pulmonary hypertension and with peripheral pulmonary stenosis

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

0 - 15 Months
  • -

  • -

Trial summary

Enrollment Goal
33
Trial Dates
February 1990 - December 1992
Phase
Phase 4
Could I Receive a placebo
N/A
Products
Adalat Retard (Nifedipine, BAYA1040)
Accepts Healthy Volunteer
N/A

Trial design

Open, non controlled, non randomised, unicenter pilot study to investigate the long-term efficacy of Adalat® drops and Adalat® retard 10 mg tablets in children with pulmonary hypertension and with peripheral pulmonary stenosis
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.